Home›Stock Screener›Sanofi›Quarterly Results

Sanofi Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹120 Cr
QMar 2025
Quarterly Results

In Mar 2025, Sanofi (SANOFI) reported revenue ₹539 Cr and net profit ₹120 Cr — revenue -6.9% YoY. View Sanofi yearly highs lows for the annual high/low range and current price position.

SANOFI Quarterly Results — Revenue, Profit & EPS Highlights

Sanofi latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Analyse SANOFI promoter holding to track promoter, FII and institutional holdings.

  • Revenue of ₹539 Cr in Mar 2025 (+2.5% vs Sept 2024, -6.9% vs Mar 2024)
  • Net Profit of ₹120 Cr in Mar 2025 (+46.3% vs Sept 2024, -12.4% vs Mar 2024)
  • EBITDA of ₹175 Cr in Mar 2025 (+43.4% vs Sept 2024)
  • Operating Margin of 32.0% in Mar 2025 (+9.0pp vs Sept 2024)
  • Earnings Per Share of ₹51.89 in Mar 2025 (+45.4% vs Sept 2024)

Sanofi Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SANOFI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 QoQ YoY
Revenue (₹ Cr) 539 526 579 503 529 2.5% -6.9%
Net Profit (₹ Cr) 120 82 137 103 91 - -
EBITDA (₹ Cr) 175 122 179 137 132 - -
EPS (₹) 51.89 35.69 59.31 44.81 39.64 - -
Operating Margin (%) 32.0% 23.0% 22.0% 21.0% 23.0% - -

SANOFI Share Price Trend — 1-Year Movement Across Quarterly Results

Sanofi 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit SANOFI share price screener.

Profitability Ratios

Profit Margin 22.3%
EBITDA Margin 32.5%
Operating Margin 32.0%
ROE (Annual) 55.7%

Balance Sheet Highlights

Total Assets ₹1,612 Cr
Total Equity ₹861 Cr
Current Assets ₹1,127 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹462 Cr
Investing Cash Flow ₹-180 Cr
Financing Cash Flow ₹-392 Cr
Net Cash Flow ₹-111 Cr

Current Market Data

Current Price ₹3087.40
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Jun 2024 503
Mar 2024 579
Sept 2024 526
Mar 2025 539

Net Profit Trend (₹ Cr)

Jun 2024 103
Mar 2024 137
Sept 2024 82
Mar 2025 120

Operating Margin Trend (%)

Jun 2024 21.0%
Mar 2024 22.0%
Sept 2024 23.0%
Mar 2025 32.0%

SANOFI vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sanofi latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Cipla
Mar 2026 		₹109,705.39 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores